File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Allo‐skin graft rejection, tumor rejection and natural killer activity in mice lacking p56lck

TitleAllo‐skin graft rejection, tumor rejection and natural killer activity in mice lacking p56<sup>lck</sup>
Authors
KeywordsGraft rejection
Tumor rejection
Natural killer cells
p56 lck
Issue Date1995
Citation
European Journal of Immunology, 1995, v. 25, n. 11, p. 3155-3159 How to Cite?
AbstractMice lacking the p56lck molecule (lck−/−) have a profound block in the maturation of thymocytes and a greatly reduced number of peripheral mature T cells. To analyze further the functions of the T cells developed in lck −/− mice in vivo, we evaluated the ability of lck−/− mice to reject allo‐skin grafts and methylcholanthrene (MCA)‐induced syngeneic fibrosarcoma, and also examined the biological activity of lck −/− natural killer (NK) cells. Mice lacking p56lck failed to reject skin grafts from either MHC‐disparate or minor‐histocompatibility‐different donors, even after they had been primed with donor spleen cells. They also failed to reject the MCA‐induced immunogenic syngeneic fibrosarcoma, MC57X. NK activity in mice lacking p56lck was normal, and there were no differences in the NK cell activation induced by poly(I) · poly(C) stimulation or interleukin‐2 stimulation (lymphokine‐activated killer induction) between mice lacking p56lck and their immunocompetent heterozygous littermates. NK cells lacking p56lck mediated a normal antibody‐dependent cell‐mediated cytotoxicity (ADCC) response. The results of this study indicate that the loss of p56lck severely impairs the effectors of the immune system which mediate the rejection of allo‐skin grafts and syngeneic tumors. The normal NK activity in lck −/− mice suggests that p56lck is not required for the development and activation of NK cells. Copyright © 1995 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
Persistent Identifierhttp://hdl.handle.net/10722/292170
ISSN
2023 Impact Factor: 4.5
2023 SCImago Journal Rankings: 1.627
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorWen, Tao-
dc.contributor.authorZhang, Li-
dc.contributor.authorKung, Sam K.P.-
dc.contributor.authorMolina, Thierry J.-
dc.contributor.authorMiller, Richard G.-
dc.contributor.authorMak, Tak W.-
dc.date.accessioned2020-11-17T14:55:54Z-
dc.date.available2020-11-17T14:55:54Z-
dc.date.issued1995-
dc.identifier.citationEuropean Journal of Immunology, 1995, v. 25, n. 11, p. 3155-3159-
dc.identifier.issn0014-2980-
dc.identifier.urihttp://hdl.handle.net/10722/292170-
dc.description.abstractMice lacking the p56lck molecule (lck−/−) have a profound block in the maturation of thymocytes and a greatly reduced number of peripheral mature T cells. To analyze further the functions of the T cells developed in lck −/− mice in vivo, we evaluated the ability of lck−/− mice to reject allo‐skin grafts and methylcholanthrene (MCA)‐induced syngeneic fibrosarcoma, and also examined the biological activity of lck −/− natural killer (NK) cells. Mice lacking p56lck failed to reject skin grafts from either MHC‐disparate or minor‐histocompatibility‐different donors, even after they had been primed with donor spleen cells. They also failed to reject the MCA‐induced immunogenic syngeneic fibrosarcoma, MC57X. NK activity in mice lacking p56lck was normal, and there were no differences in the NK cell activation induced by poly(I) · poly(C) stimulation or interleukin‐2 stimulation (lymphokine‐activated killer induction) between mice lacking p56lck and their immunocompetent heterozygous littermates. NK cells lacking p56lck mediated a normal antibody‐dependent cell‐mediated cytotoxicity (ADCC) response. The results of this study indicate that the loss of p56lck severely impairs the effectors of the immune system which mediate the rejection of allo‐skin grafts and syngeneic tumors. The normal NK activity in lck −/− mice suggests that p56lck is not required for the development and activation of NK cells. Copyright © 1995 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim-
dc.languageeng-
dc.relation.ispartofEuropean Journal of Immunology-
dc.subjectGraft rejection-
dc.subjectTumor rejection-
dc.subjectNatural killer cells-
dc.subjectp56 lck-
dc.titleAllo‐skin graft rejection, tumor rejection and natural killer activity in mice lacking p56<sup>lck</sup>-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1002/eji.1830251125-
dc.identifier.pmid7489757-
dc.identifier.scopuseid_2-s2.0-0028850062-
dc.identifier.volume25-
dc.identifier.issue11-
dc.identifier.spage3155-
dc.identifier.epage3159-
dc.identifier.eissn1521-4141-
dc.identifier.isiWOS:A1995TE64700024-
dc.identifier.issnl0014-2980-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats